you are here: Home News Sun Pharmaceutical

Sun Pharmaceutical

Sun Pharma Q1 Results: Net profit jumps 40% on-year to Rs 2,836 crore, beats estimates
Sun Pharma shares decline on report of four observations from US FDA
NPPA makes 33 fixed-dose combination drugs cheaper, brings them under regulation
Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues
Sun Pharmaceutical recalls over 10,000 bottles of generic anti-depression drug in US
Aurobindo, Sun Pharma recall products in US market
Buy Sun Pharmaceutical; target of Rs 786: Dolat Capital Market
Lupin, Sun Pharma recall drugs in the US market
Sun Pharma board to consider share buyback plan next week
Sun Pharma launches severe nodular acne management capsules in US
Sun Pharma inks global licensing pact with CSIR-IICT for patents
Sun Pharmaceutical launched cancer drug in US market
Sun Pharma recalls about 14k cartons of anaesthesia injection from US market
Glenmark gets USFDA nod for skin ointment
A morning walk down Dalal Street | Nifty to find support around 10,750, stay cautious while picking stocks
Market Headstart: Nifty likely to open above 10,900; 3 stocks that could return 3-5%
Podcast | Stock Picks of the Day: Nifty may face resistance around 10,950; 3 trading ideas for Dec series
A morning walk down Dalal Street | Market likely to remain volatile ahead of MPC meet outcome with support at 10,650
Sun Pharma gets Australia TGA nod for plaque psoriasis treatment drug
Sun Pharmaceutical signs Virat Kohli as brand ambassador for Volini
Accumulate Sun Pharmaceutical; target of Rs 539: KRChoksey
Sun Pharma recalls over 17.5 K bottles of nasal spray from US
Sun Pharmaceutical – is the dawn near?
Prefer Dr Reddy's, Sun Pharmaceutical: Hemant Thukral
Buy Bharat Forge, Colgate, Federal Bank; sell Sun Pharma: Ashwani Gujral

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Sun Pharmaceutical

Sun Pharma Q1 Results: Net profit jumps 40% on-year to Rs 2,836 crore, beats estimates

Sun Pharma shares decline on report of four observations from US FDA

NPPA makes 33 fixed-dose combination drugs cheaper, brings them under regulation

Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

Sun Pharmaceutical recalls over 10,000 bottles of generic anti-depression drug in US

Aurobindo, Sun Pharma recall products in US market

Buy Sun Pharmaceutical; target of Rs 786: Dolat Capital Market

Lupin, Sun Pharma recall drugs in the US market

Sun Pharma board to consider share buyback plan next week

Sun Pharma launches severe nodular acne management capsules in US

Sun Pharma inks global licensing pact with CSIR-IICT for patents

Sun Pharmaceutical launched cancer drug in US market

Sun Pharma recalls about 14k cartons of anaesthesia injection from US market

Glenmark gets USFDA nod for skin ointment

A morning walk down Dalal Street | Nifty to find support around 10,750, stay cautious while picking stocks

Market Headstart: Nifty likely to open above 10,900; 3 stocks that could return 3-5%

Podcast | Stock Picks of the Day: Nifty may face resistance around 10,950; 3 trading ideas for Dec series

A morning walk down Dalal Street | Market likely to remain volatile ahead of MPC meet outcome with support at 10,650

Sun Pharma gets Australia TGA nod for plaque psoriasis treatment drug

Sun Pharmaceutical signs Virat Kohli as brand ambassador for Volini

Accumulate Sun Pharmaceutical; target of Rs 539: KRChoksey

Sun Pharma recalls over 17.5 K bottles of nasal spray from US

Sun Pharmaceutical – is the dawn near?

Prefer Dr Reddy's, Sun Pharmaceutical: Hemant Thukral

Buy Bharat Forge, Colgate, Federal Bank; sell Sun Pharma: Ashwani Gujral